Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype is a research paper published in Cell Death and Disease (2021). On theSindex it has a DataRank of 0. It has been cited 36 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
FWCI
2.14
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer
Additional file 1 of Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer
Additional file 2 of Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer
Additional file 2 of Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer
Additional file 3 of Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer
Additional file 3 of Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer
Additional file 4 of Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer
Additional file 4 of Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer